EUVIMEDEUVIMED entdecken
Crossref

Serum Endocan Levels in Adult Asthma Patients: A Controlled Study Investigating Associations With Disease Severity and Asthma Control

Aydın COL, Onur YAZICI, Cigdem YENISEY

Asthma Allergy Immunology · 23.12.2025 · 23 (3) · 233-241

DOI: 10.21911/aai.2025.841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asthma Allergy Immunology, online erschienen am 23.12.2025. Verfasst von Aydın COL und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

COL, A., YAZICI, O., & YENISEY, C. (2025). Serum Endocan Levels in Adult Asthma Patients: A Controlled Study Investigating Associations With Disease Severity and Asthma Control. Asthma Allergy Immunology, 23(3), 233-241. https://doi.org/10.21911/aai.2025.841

Vancouver

COL A, YAZICI O, YENISEY C. Serum Endocan Levels in Adult Asthma Patients: A Controlled Study Investigating Associations With Disease Severity and Asthma Control. Asthma Allergy Immunology. 2025;23(3):233-241. doi:10.21911/aai.2025.841

BibTeX
@article{COL2025,
  author = {COL, Aydın and YAZICI, Onur and YENISEY, Cigdem},
  title = {Serum Endocan Levels in Adult Asthma Patients: A Controlled Study Investigating Associations With Disease Severity and Asthma Control},
  journal = {Asthma Allergy Immunology},
  year = {2025},
  volume = {23},
  number = {3},
  pages = {233--241},
  doi = {10.21911/aai.2025.841}
}
Kostenlos starten →